Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
pathological response
Description:
The degree of tumor change or residual disease found by pathological examination after treatment, especially neoadjuvant cancer therapy.
Related topics:
Breast Cancer Treatment Studies (15%),
Esophageal Cancer Research and Treatment (10%),
Colorectal Cancer Surgical Treatments (9%),
Gastric Cancer Management and Outcomes (7%),
Lung Cancer Diagnosis and Treatment (7%)
OpenAlex ID:
keywords/pathological-response
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
2018
·
Patrick M. Forde
, Jamie E. Chaft
, et al.
·
New England Journal of Medicine
·
2,193
PDF
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
2007
·
W. Fraser Symmans
, Florentia Peintinger
, et al.
·
Journal of Clinical Oncology
·
1,715
PDF
Pathological features of rectal cancer after preoperative radiochemotherapy
1997
·
O. Dworak
, L. Keilholz
, et al.
·
International Journal of Colorectal Disease
·
1,355
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
2023
·
Heather Wakelee
, Moishe Liberman
, et al.
·
New England Journal of Medicine
·
1,344
PDF
Prognostic Significance of Tumor Regression After Preoperative Chemoradiotherapy for Rectal Cancer
2005
·
Claus Rödel
, Peter Martus
, et al.
·
Journal of Clinical Oncology
·
1,224
Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis
2005
·
D. Mauri
, N. Pavlidis
, et al.
·
JNCI Journal of the National Cancer Institute
·
1,224
A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival
2003
·
Keith N Ogston
, Iain D Miller
, et al.
·
The Breast
·
1,011
Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03
2009
·
Mark S. Roh
, Linda H. Colangelo
, et al.
·
Journal of Clinical Oncology
·
944
Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease
2008
·
Matthew H.G. Katz
, Peter W.T. Pisters
, et al.
·
Journal of the American College of Surgeons
·
838
Pathological response following long‐course neoadjuvant chemoradiotherapy for locally advanced rectal cancer
2005
·
R Ryan
, D Gibbons
, et al.
·
Histopathology
·
751
A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer
2011
·
Christos Hatzis
, Lajos Pusztai
, et al.
·
JAMA
·
716
A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma
2019
·
Alexander C. Huang
, Robert J. Orlowski
, et al.
·
Nature Medicine
·
710
Deep Learning Predicts Lung Cancer Treatment Response from Serial Medical Imaging
2019
·
Yiwen Xu
, Ahmed Hosny
, et al.
·
Clinical Cancer Research
·
683
PDF
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma
2024
·
Christian U. Blank
, Minke W. Lucas
, et al.
·
New England Journal of Medicine
·
618
Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases
2008
·
Dan G. Blazer
, Yoji Kishi
, et al.
·
Journal of Clinical Oncology
·
614
Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair–Deficient Colon Cancer
2024
·
Myriam Chalabi
, Yara L. Verschoor
, et al.
·
New England Journal of Medicine
·
560
PDF
Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial
2019
·
Elisa A Rozeman
, Alexander M Menzies
, et al.
·
The Lancet Oncology
·
556
Neoadjuvant Treatment Response As an Early Response Indicator for Patients With Rectal Cancer
2012
·
In Ja Park
, Y. Nancy You
, et al.
·
Journal of Clinical Oncology
·
492
Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)
2021
·
Alexander M. Menzies
, Rodabe N. Amaria
, et al.
·
Nature Medicine
·
477
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
2019
·
Mark J. Truty
, Michael L. Kendrick
, et al.
·
Annals of Surgery
·
457
Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome.
1995
·
D M Sataloff
, B A Mason
, et al.
·
PubMed
·
428
Pathobiology of preoperative chemotherapy: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) protocol B‐18
2002
·
Edwin R. Fisher
, Jiping Wang
, et al.
·
Cancer
·
412
PDF
Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer
2021
·
Jamie E. Chaft
, Andreas Rimner
, et al.
·
Nature Reviews Clinical Oncology
·
411
Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial
2022
·
Irene L. M. Reijers
, Alexander M. Menzies
, et al.
·
Nature Medicine
·
406
PDF
Positron Emission Tomography Using [18F]-Fluorodeoxy- d -Glucose to Predict the Pathologic Response of Breast Cancer to Primary Chemotherapy
2000
·
Ian C. Smith
, Andrew E. Welch
, et al.
·
Journal of Clinical Oncology
·
406
Show more works
View as search
Works count:
5,574
Citation count:
101,700
Year
Topic
Type